Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice. Critical review of the literature by a medical panel.

Mortuaire, G; de Gabory, L; François, M; Massé, G; Bloch, F; Brion, N; Jankowski, R; Serrano, E

Mortuaire, G; de Gabory, L; François, M; Massé, G; Bloch, F; Brion, N; Jankowski, R; Serrano, E.

Affiliation

Mortuaire G; Service d'ORL et de chirurgie cervico-faciale, hôpital Huriez, CHRU de Lille, rue Michel-Polonovski, 59037 Lille cedex, France. g-mortuaire@chru-lille.fr

Eur Ann Otorhinolaryngol Head Neck Dis ; 130(3): 137-44, 2013 Jun.

Article in En | MEDLINE | ID: mdl-23375990

Subject(s)

Nasal Decongestants/adverse effects; Nasal Mucosa/drug effects; Rhinitis/chemically induced; Rhinitis/drug therapy; Advisory Committees; Animals; Evidence-Based Medicine; Government Agencies; Humans; Nasal Decongestants/administration & dosage; Nasal Mucosa/pathology; Practice Guidelines as Topic

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nasal Decongestants / Rhinitis / Nasal Mucosa Type of study: Guideline / Prognostic_studies / Qualitative_research Limits: Animals / Humans Language: En Journal: Eur Ann Otorhinolaryngol Head Neck Dis Year: 2013 Document type: Article

Fulltext

XML

PubMed Links

Search on Google